Douglas L. Mann
#84,359
Most Influential Person Now
Researcher
Douglas L. Mann's AcademicInfluence.com Rankings
Douglas L. Mannphilosophy Degrees
Philosophy
#3311
World Rank
#5376
Historical Rank
Logic
#1079
World Rank
#1717
Historical Rank
Douglas L. Mannbiology Degrees
Biology
#3896
World Rank
#5894
Historical Rank
Biochemistry
#418
World Rank
#497
Historical Rank
Download Badge
Philosophy Biology
Why Is Douglas L. Mann Influential?
(Suggest an Edit or Addition)According to Wikipedia, Douglas L. Mann is an American physician. He is currently the Lewin Distinguished Professor in Cardiovascular Diseases and professor of medicine, cell biology and physiology at Washington University School of Medicine in St. Louis.
Douglas L. Mann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) (1999) (4830)
- Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features (2011) (2064)
- The Seattle Heart Failure Model: Prediction of Survival in Heart Failure (2006) (1797)
- Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). (1996) (1257)
- Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) (2004) (1127)
- Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. (2014) (1041)
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. (2013) (1013)
- Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST) (2001) (997)
- Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart (1996) (957)
- Inflammatory mediators and the failing heart: past, present, and the foreseeable future. (2002) (927)
- Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte (1992) (902)
- Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. (1998) (837)
- Mechanisms and models in heart failure: the biomechanical model and beyond. (2005) (811)
- Mechanisms and models in heart failure: A combinatorial approach. (1999) (806)
- Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. (1993) (734)
- Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th edition (2018) (620)
- TNF‐α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle (2005) (590)
- Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart (2014) (530)
- Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy (2001) (524)
- Warfarin and aspirin in patients with heart failure and sinus rhythm. (2012) (511)
- Innate immunity and the failing heart: the cytokine hypothesis revisited. (2015) (478)
- Desmin mutation responsible for idiopathic dilated cardiomyopathy. (1999) (457)
- Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. (2000) (454)
- Role of innate and adaptive immune mechanisms in cardiac injury and repair (2015) (448)
- Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. (1995) (444)
- Basic mechanisms in heart failure: the cytokine hypothesis. (1996) (441)
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. (2016) (420)
- Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. (2013) (417)
- Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. (1999) (406)
- Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. (1994) (400)
- Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure (2001) (381)
- Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. (1999) (375)
- Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor (2001) (374)
- Expression and functional significance of tumor necrosis factor receptors in human myocardium. (1995) (369)
- Deep RNA Sequencing Reveals Dynamic Regulation of Myocardial Noncoding RNAs in Failing Human Heart and Remodeling With Mechanical Circulatory Support (2014) (365)
- Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. (2008) (362)
- Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. (1996) (354)
- Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte* (1997) (341)
- Tumor Necrosis Factor-α Provokes a Hypertrophic Growth Response in Adult Cardiac Myocytes (1997) (338)
- The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. (2011) (313)
- Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. (1997) (310)
- Stress-activated cytokines and the heart: from adaptation to maladaptation. (2003) (303)
- Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model (2007) (291)
- Neurohormonal activation in heart failure with reduced ejection fraction (2017) (288)
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic science (2011) (280)
- The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure (2008) (257)
- Reappraising the role of inflammation in heart failure (2020) (256)
- Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial. (2016) (255)
- Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. (2010) (250)
- Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. (2005) (231)
- TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. (2007) (230)
- Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. (2006) (227)
- Cardiac-Specific Overexpression of Tumor Necrosis Factor-&agr; Causes Oxidative Stress and Contractile Dysfunction in Mouse Diaphragm (2000) (223)
- In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. (2001) (222)
- Load Regulation of the Properties of Adult Feline Cardiocytes: Growth Induction by Cellular Deformation (1989) (218)
- Circulating interleukin-6 in severe heart failure. (1997) (217)
- Myocardial recovery and the failing heart: myth, magic, or molecular target? (2012) (210)
- Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation. (2019) (205)
- Braunwald's heart disease (2015) (190)
- Biomarkers of inflammation in heart failure (2010) (187)
- Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). (2011) (182)
- Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. (1998) (179)
- Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. (2002) (172)
- Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. (2002) (170)
- The continuous heart failure spectrum: moving beyond an ejection fraction classification. (2019) (170)
- Differential expression of heat shock proteins in normal and failing human hearts. (1998) (169)
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial (2018) (167)
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study (2015) (166)
- Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. (1997) (165)
- Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial (2017) (161)
- Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. (1992) (160)
- Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study. (2014) (157)
- Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. (2008) (152)
- Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. (1998) (149)
- Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. (2012) (149)
- Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. (1999) (138)
- Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. (2005) (136)
- Load-Dependent and -Independent Regulation of Proinflammatory Cytokine and Cytokine Receptor Gene Expression in the Adult Mammalian Heart (2002) (135)
- Angiotensin II Induces Tumor Necrosis Factor Biosynthesis in the Adult Mammalian Heart Through a Protein Kinase C-Dependent Pathway (2002) (134)
- A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. (2018) (133)
- Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. (2004) (132)
- Role of MicroRNAs in Cardiac Remodeling and Heart Failure (2011) (130)
- Clinical Evaluation of the CorCap Cardiac Support Device in Patients With Dilated Cardiomyopathy (2005) (129)
- Necrotic Myocardial Cells Release Damage-Associated Molecular Patterns That Provoke Fibroblast Activation In Vitro and Trigger Myocardial Inflammation and Fibrosis In Vivo (2015) (128)
- CD14-Deficient Mice Are Protected Against Lipopolysaccharide-Induced Cardiac Inflammation and Left Ventricular Dysfunction (2002) (126)
- Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. (2007) (125)
- Extracellular matrix remodeling following myocardial injury (2003) (123)
- Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. (2000) (121)
- A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial) (2015) (120)
- Hemodynamic Effects of Tezosentan, an Intravenous Dual Endothelin Receptor Antagonist, in Patients With Class III to IV Congestive Heart Failure (2001) (119)
- The role of cytokines in the failing human heart. (1998) (118)
- One‐year follow‐up results from AUGMENT‐HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure (2016) (117)
- Nuclear Factor-&kgr;B Protects the Adult Cardiac Myocyte Against Ischemia-Induced Apoptosis in a Murine Model of Acute Myocardial Infarction (2003) (115)
- Acute decompensated heart failure: contemporary medical management. (2009) (115)
- Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial. (2007) (114)
- Stress activated cytokines and the heart. (1996) (113)
- Comparable Performance of the Kansas City Cardiomyopathy Questionnaire in Patients With Heart Failure With Preserved and Reduced Ejection Fraction (2013) (113)
- Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid‐range ejection fraction (2017) (112)
- The role of cytokines in disease progression in heart failure. (1997) (112)
- Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. (2000) (110)
- Targeted anticytokine therapy and the failing heart. (2005) (109)
- Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. (2012) (106)
- Diabetic cardiomyopathy: bench to bedside. (2012) (105)
- Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. (2002) (105)
- Effects of Tumor Necrosis Factor Gene Polymorphisms on Patients With Congestive Heart Failure (1998) (104)
- Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. (2007) (103)
- Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. (2020) (101)
- Inflammatory mediators and the failing heart: a translational approach. (2003) (100)
- Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure (2004) (100)
- Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. (1991) (99)
- Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. (1995) (98)
- Adaptive and Maladptive Effects of SMAD3 Signaling in the Adult Heart After Hemodynamic Pressure Overloading (2009) (97)
- Differential Regulation of Mitogen-Activated Protein Kinases in the Failing Human Heart in Response to Mechanical Unloading (2001) (97)
- Cellular remodeling in heart failure disrupts KATP channel‐dependent stress tolerance (2003) (96)
- An overview of tumor necrosis factor α and the failing human heart (1999) (95)
- Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. (2003) (94)
- Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study. (2016) (91)
- Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18 (2015) (90)
- Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure. (2004) (89)
- Heart Failure: a Companion to Braunwald's Heart Disease (2014) (89)
- Hypogonadism in male patients with cancer (2006) (89)
- NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. (2010) (89)
- Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac Phenotypes (2004) (86)
- Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. (2010) (86)
- Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial. (2012) (85)
- Nitric Oxide Provokes Tumor Necrosis Factor-&agr; Expression in Adult Feline Myocardium Through a cGMP-Dependent Pathway (2000) (85)
- Recent Insights into the Role of Tumor Necrosis Factor in the Failing Heart (2001) (84)
- Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials. (2008) (84)
- Tumor necrosis factor-alpha-induced expression of heat shock protein 72 in adult feline cardiac myocytes. (1996) (82)
- Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. (2008) (81)
- Blocking the Endogenous Increase in HSP 72 Increases Susceptibility to Hypoxia and Reoxygenation in Isolated Adult Feline Cardiocytes (1996) (81)
- Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group. (2016) (80)
- Comprar Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features | Peter Libby | 9781437727081 | Saunders (2011) (79)
- Activation and Functional Significance of the Renin-Angiotensin System in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor (2003) (78)
- The Development of Myocardial Fibrosis in Transgenic Mice With Targeted Overexpression of Tumor Necrosis Factor Requires Mast Cell–Fibroblast Interactions (2011) (78)
- Transforming growth factor-β receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor (2007) (77)
- Pathophysiology of Heart Failure (2012) (76)
- Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation (2003) (76)
- Safety and Efficacy of a Soluble P 75 Tumor Necrosis Factor Receptor ( Enbrel , Etanercept ) in Patients With Advanced Heart Failure (1999) (75)
- Cytokines as emerging targets in the treatment of heart failure. (2000) (75)
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The EXACT-HF Study (2015) (75)
- Positioning of Inflammatory Biomarkers in the Heart Failure Landscape (2013) (74)
- Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial. (2011) (73)
- The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. (2000) (72)
- Role of inflammatory cells in fibroblast activation. (2016) (71)
- Basic mechanisms of disease progression in the failing heart: the role of excessive adrenergic drive. (1998) (71)
- Brief murine myocardial I/R induces chemokines in a TNF-alpha-independent manner: role of oxygen radicals. (2001) (70)
- Cytokines in heart failure: pathogenetic mechanisms and potential treatment. (1999) (69)
- Epidemiology and Natural History of Recovery of Left Ventricular Function in Recent Onset Dilated Cardiomyopathies (2013) (69)
- Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype (2003) (69)
- Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization. (2015) (68)
- Cardiac remodeling as a consequence and cause of progressive heart failure (1998) (68)
- Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial Ischemia (2005) (68)
- Cross-sectional echocardiographic assessment of regional left ventricular performance and myocardial perfusion. (1986) (68)
- Increased Myocardial Gene Expression of Tumor Necrosis Factor-&agr; and Nitric Oxide Synthase-2: A Potential Mechanism for Depressed Myocardial Function in Hibernating Myocardium in Humans (2002) (68)
- Effects of changes in left ventricular contractility on indexes of contractility in mice. (2002) (68)
- Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. (2003) (64)
- Contractile function of isolated feline cardiocytes in response to viscous loading. (1989) (64)
- Improving outcomes in heart failure: It's not unusual beyond usual care. (2002) (64)
- Effects of Phosphodiesterase Type 5 Inhibition on Systemic and Pulmonary Hemodynamics and Ventricular Function in Patients With Severe Symptomatic Aortic Stenosis (2012) (64)
- Imaging systemic inflammatory networks in ischemic heart disease. (2015) (63)
- New therapeutics for chronic heart failure. (2002) (62)
- Tumor necrosis factor-induced signal transduction and left ventricular remodeling. (2002) (62)
- The Cytoprotective Effects of Tumor Necrosis Factor Are Conveyed Through Tumor Necrosis Factor Receptor–Associated Factor 2 in the Heart (2010) (61)
- Widespread Down-Regulation of Cardiac Mitochondrial and Sarcomeric Genes in Patients With Sepsis* (2017) (61)
- Desmin mediates TNF-α–induced aggregate formation and intercalated disk reorganization in heart failure (2008) (61)
- Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far? (1998) (60)
- Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes. (2008) (60)
- Treatment of the metabolic syndrome: The impact of lifestyle modification (2005) (59)
- MicroRNAs and the failing heart. (2007) (59)
- Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure. (2004) (57)
- The Adverse Impact of Diabetes Mellitus on Left Ventricular Remodeling and Function in Patients With Severe Aortic Stenosis (2011) (57)
- Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. (2021) (57)
- Load induction of cardiac hypertrophy. (1989) (56)
- Shortness of Breath (2003) (56)
- Autonomic Modulation for the Management of Patients with Chronic Heart Failure (2015) (55)
- Duality of innate stress responses in cardiac injury, repair, and remodeling. (2004) (55)
- Basic mechanisms of left ventricular remodeling: the contribution of wall stress. (2004) (55)
- Speckle Strain Echocardiography Predicts Outcome in Patients with Heart Failure with both Depressed and Preserved Left Ventricular Ejection Fraction (2015) (55)
- Functional Significance of Hemodynamic Overload–Induced Expression of Leukemia-Inhibitory Factor in the Adult Mammalian Heart (2001) (55)
- The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy. (2016) (55)
- Abnormal Global Longitudinal Strain Predicts Future Deterioration of Left Ventricular Function in Heart Failure Patients With a Recovered Left Ventricular Ejection Fraction (2017) (53)
- Cardiac remodelling and myocardial recovery: lost in translation? (2010) (53)
- Innate immunity in the adult mammalian heart: for whom the cell tolls. (2010) (52)
- Regulation of cardiac fibroblast cellular function by leukemia inhibitory factor. (2002) (52)
- Exercise training and skeletal muscle inflammation in chronic heart failure: feeling better about fatigue. (2003) (52)
- The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results. (2015) (52)
- Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure (2004) (52)
- Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial (2016) (52)
- Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. (2021) (51)
- The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines. (1996) (51)
- Oxidative Stress Promotes Ligand-independent and Enhanced Ligand-dependent Tumor Necrosis Factor Receptor Signaling* (2008) (51)
- Blocking the endogenous increase in HSP 72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes. (1997) (51)
- Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete? (2017) (51)
- The role of innate immune responses in the heart in health and disease. (2004) (50)
- Management of Heart Failure Patients with Reduced Ejection Fraction (2010) (50)
- Tumor necrosis factor and viral myocarditis: the fine line between innate and inappropriate immune responses in the heart. (2001) (49)
- Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. (2008) (49)
- Left Ventricular Size and Shape: Determinants of Mechanical Signal Transduction Pathways (2005) (49)
- Role of the Innate Immune System in Acute Viral Myocarditis (2009) (48)
- Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury. (2018) (48)
- Expression of a Mutation Causing Hypertrophic Cardiomyopathy Disrupts Sarcomere Assembly in Adult Feline Cardiac Myocytes (1995) (48)
- Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose. (2003) (48)
- Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways. (2010) (47)
- Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study. (2019) (47)
- Impact of Preeclampsia on Clinical and Functional Outcomes in Women With Peripartum Cardiomyopathy (2017) (46)
- Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy (2005) (46)
- Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy. (2014) (44)
- HFSA 2010 Guideline Executive Summary Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline (2006) (44)
- Use of biomarkers in the management of heart failure: are we there yet? (2003) (43)
- Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. (1995) (43)
- Apoptosis and the heart: a decade of progress. (2005) (43)
- Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction. (2020) (42)
- Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. (2004) (42)
- Dialysis-induced alterations in left ventricular filling: mechanisms and clinical significance. (1991) (42)
- An overview of tumor necrosis factor alpha and the failing human heart. (1999) (42)
- Tumor necrosis factor‐α and the failing human heart–TNFα and heart failure (1995) (40)
- Incidence and Clinical Significance (2015) (40)
- Therapeutic targeting of innate immunity in the failing heart. (2011) (39)
- Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics (2021) (39)
- Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM‐HF, INOVATE‐HF, and NECTAR‐HF (2020) (38)
- Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. (2020) (38)
- Cardiac disease in cancer patients: an overview. (2010) (37)
- Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. (2011) (37)
- Hepcidin in anemia of chronic heart failure (2011) (36)
- Soluble Tumor Necrosis Factor Receptors and Heart Failure Risk in Older Adults: Health, Aging, and Body Composition (Health ABC) Study (2013) (36)
- Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. (1998) (35)
- New Predictive Models of Heart Failure Mortality Using Time-Series Measurements and Ensemble Models (2011) (35)
- Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction (2020) (35)
- Tumor necrosis factor-alpha and the failing human heart. (1995) (34)
- Effects of age on ventricular performance during graded supine exercise. (1986) (34)
- Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. (2002) (33)
- Inflammatory mediators in heart failure: homogeneity through heterogeneity (1999) (33)
- Targeted cancer therapeutics: the heartbreak of success (2006) (32)
- Inhibition of PPAR-α activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-β/Smad3 (2007) (32)
- Failure of benefit and early hazard of bucindolol for Class IV heart failure. (2003) (31)
- Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart: recovering the missing link in left ventricular remodeling. (2001) (31)
- Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure (2018) (31)
- Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study. (2012) (30)
- Dysferlin Mediates the Cytoprotective Effects of TRAF2 Following Myocardial Ischemia Reperfusion Injury (2014) (30)
- Functional significance of the discordance between transcriptional profile and left ventricular structure/function during reverse remodeling. (2016) (30)
- Neuromodulation of the Failing Heart (2016) (30)
- Normalization of cardiac structure and function after regression of cardiac hypertrophy. (1994) (29)
- Pitfalls in measuring cytokines. (1994) (29)
- Cardiocyte contractile performance in experimental biventricular volume-overload hypertrophy. (1993) (29)
- Effects of chronic mitral regurgitation on diastolic function in isolated cardiocytes. (1993) (29)
- Tumor Necrosis Factor Receptor–Associated Factor 2 Signaling Provokes Adverse Cardiac Remodeling in the Adult Mammalian Heart (2013) (29)
- Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm: A Subgroup Analysis of WARCEF, a Randomized Controlled Trial (2013) (29)
- Group B Streptococcus induces TNF-alpha gene expression and activation of the transcription factors NF-kappa B and activator protein-1 in human cord blood monocytes. (2000) (28)
- Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Biomarker Substudy of the Surgical Treatment for Ischemic Heart Failure Trials (2013) (28)
- COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities (2020) (28)
- Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients: Design and Rationale of the EXACT-HF Study (2013) (28)
- Communication in the Heart: the Role of the Innate Immune System in Coordinating Cellular Responses to Ischemic Injury (2012) (28)
- Tumor necrosis factor-alpha is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection. (1998) (28)
- Clinical applications of miRNAs in cardiac remodeling and heart failure. (2010) (27)
- Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure (2020) (27)
- Functional significance of inflammatory mediators in a murine model of resuscitated hemorrhagic shock. (2005) (27)
- Group B Streptococcus Induces TNF-α Gene Expression and Activation of the Transcription Factors NF-κB and Activator Protein-1 in Human Cord Blood Monocytes1 (2000) (27)
- The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients. (2015) (27)
- Serum biomarkers in severe refractory cardiogenic shock. (2013) (26)
- Absence of cardioversion-induced ventricular arrhythmias in patients with therapeutic digoxin levels. (1985) (26)
- Prevalence of lactic acidaemia in patients with advanced heart failure and depressed cardiac output (2016) (26)
- Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (2014) (26)
- Effect of the Soluble TNF‐Antagonist Etanercept on Tumor Necrosis Factor Bioactivity and Stability (2008) (25)
- Signals for cardiac muscle hypertrophy in hypertension. (1991) (25)
- Cardiac Contractility Modulation in 2018. (2018) (25)
- Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy (2020) (25)
- Diagnosis and management of adult hereditary cardio-neuromuscular disorders: A model for the multidisciplinary care of complex genetic disorders. (2017) (25)
- Status of Early-Career Academic Cardiology: A Global Perspective. (2017) (24)
- Left ventricular assist device-induced reverse remodeling: it’s not just about myocardial recovery (2017) (24)
- New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. (2012) (24)
- Single- versus dual-chamber sensor-driven pacing: comparison of cardiac outputs. (1991) (24)
- INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry. (2020) (24)
- The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis. (2016) (23)
- Downregulation of connexin 40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor (2006) (23)
- Angiotensin II as an Inflammatory Mediator: Evolving Concepts in the Role of the Renin Angiotensin System in the Failing Heart (2004) (23)
- Advanced heart failure and transplant cardiology: a subspecialty is born. (2009) (22)
- The fractional shortening-velocity ratio: validation of a new echocardiographic Doppler method for identifying patients with significant aortic stenosis. (1990) (22)
- Is Myocardial Recovery Possible and How Do You Measure It? (2012) (22)
- The Emerging Role of B Lymphocytes in Cardiovascular Disease. (2020) (21)
- NEUROMODULATION OF THE FAILING HEART: LOST IN TRANSLATION? (2016) (21)
- Catheter-induced tricuspid regurgitation. Incidence and clinical significance. (1991) (21)
- Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. (2015) (21)
- Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. (2010) (21)
- Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial. (2001) (20)
- Mitochondrial tolerance to stress impaired in failing heart. (2003) (20)
- Spectrum of pleiotropic effects of statins in heart failure. (2008) (20)
- Signals for cardiac muscle hypertrophy in hypertension (1991) (20)
- Repetitive Myocardial Ischemia Promotes Coronary Growth in the Adult Mammalian Heart (2013) (20)
- Inhibition of PPAR-alpha activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3. (2007) (19)
- CHA2DS2‐VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm (2016) (19)
- Immunomodulatory role of non-neuronal cholinergic signaling in myocardial injury. (2019) (19)
- Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF. (2019) (19)
- Plasma concentrations of tumor necrosis factor-α in cats with congestive heart failure (2002) (19)
- Soluble Tumor Necrosis Factor Receptors and Heart Failure Risk in Older AdultsClinical Perspective (2014) (19)
- Heart Failure Diagnosis, Readmission, and Mortality Prediction Using Machine Learning and Artificial Intelligence Models (2020) (18)
- The emerging role of statins in the treatment of heart failure. (2006) (18)
- Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. (2011) (18)
- Coronary Collaterals Predict Improved Survival and Allograft Function in Patients With Coronary Allograft Vasculopathy (2013) (18)
- Contemporary Medical Options for Treating Patients With Heart Failure (2002) (18)
- Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease (2016) (18)
- Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment (2018) (18)
- Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus RhythmClinical Perspective (2013) (17)
- Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. (2021) (17)
- Circulating p53-responsive microRNAs as predictive biomarkers in heart failure after acute myocardial infarction: the long and arduous road from scientific discovery to clinical utility. (2013) (17)
- Designs for mechanical circulatory support device studies. (2007) (17)
- The pharmacokinetics of etanercept in patients with heart failure. (2001) (17)
- Are Synthetic Data Derivatives the Future of Translational Medicine? (2018) (17)
- Prediction of Survival in Heart Failure (2006) (16)
- The first prognostic model for stroke and death in patients with systolic heart failure. (2016) (16)
- Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses. (2001) (16)
- Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: has the time come for randomized clinical trials? (2001) (16)
- COVID-19 Clinical Trials (2020) (16)
- Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performance. (2020) (16)
- Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (2014) (16)
- TNF receptor-activated factor 2 mediates cardiac protection through noncanonical NF-κB signaling. (2018) (16)
- Is inflammation good for the ischemic heart – perspectives beyond the ordinary (2000) (15)
- Tumor necrosis factor-α and failing human heart (1995) (15)
- Relationship of functional recovery to scar contraction after myocardial infarction in the canine left ventricle. (1989) (15)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. (2012) (15)
- Impaired Protein Quality Control During Left Ventricular Remodeling in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor (2017) (15)
- The metabolic syndrome and mortality in an ethnically diverse heart failure population. (2008) (15)
- Veterans Affairs Quality Enhancement Research Initiative in chronic heart failure. (2000) (15)
- Myocardial expression levels of micro-ribonucleic acids in patients with left ventricular assist devices signature of myocardial recovery, signature of reverse remodeling, or signature with no name? (2011) (14)
- National Institutes of Health Career Development Awards for Cardiovascular Physician-Scientists: Recent Trends and Strategies for Success. (2015) (14)
- Ambulatory Advanced Heart Failure in Women: A Report From the REVIVAL Registry. (2019) (14)
- Anti-angiotensin therapy: new perspectives. (2007) (14)
- Introducing JACC: Basic to Translational Science (2016) (14)
- Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure. (2021) (14)
- Targeting Myocardial Energetics in the Failing Heart: Are We There Yet? (2017) (14)
- The Emerging Role of Small Non-coding RNAs in the Failing Heart: Big Hopes for Small Molecules (2011) (13)
- Relation of tissue Doppler-derived myocardial velocities to serum levels and myocardial gene expression of tumor necrosis factor-alpha and inducible nitric oxide synthase in patients with ischemic cardiomyopathy having coronary artery bypass grafting. (2002) (13)
- TNFα decreases αMHC expression by a NO mediated pathway: Role of E-box transcription factors for cardiomyocyte specific gene regulation (2002) (13)
- Improvement of ejection fraction and mortality in ischaemic heart failure (2020) (13)
- A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials (2015) (12)
- Advanced heart failure and transplant cardiology: a subspecialty is born. (2009) (12)
- Antiinflammatory therapy in myocarditis (2003) (12)
- Left ventricular volume during supine exercise: importance of myocardial scar in patients with coronary heart disease. (1987) (12)
- Rethinking Phase II Clinical Trial Design in Heart Failure. (2013) (12)
- Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study. (2019) (11)
- Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017 (2021) (11)
- The vagus nerve and autonomic imbalance in heart failure: past, present, and future (2011) (11)
- Functional relation between infarct thickness and regional systolic function in the acutely and subacutely infarcted canine left ventricle. (1989) (10)
- Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers. (2012) (10)
- Developmental changes in myocardial B cells mirror changes in B cells associated with different organs (2020) (10)
- Cross-sectional echocardiographic characterization of atelectatic lung segments. Differentiation from extracardiac tumors. (1990) (10)
- Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. (2010) (10)
- The COMET trial. (2005) (10)
- Tumor necrosis factor alpha and cardiac remodeling (1995) (10)
- Mechanisms and Models in Heart Failure: A Translational Approach. (2021) (9)
- CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction (2016) (9)
- Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial. (2016) (9)
- Inflammation and Cardiac Diseases (2003) (9)
- Plasma concentrations of tumor necrosis factor-alpha in cats with congestive heart failure. (2002) (9)
- How to Build an Integrated Biobank: The Washington University Translational Cardiovascular Biobank & Repository Experience (2013) (8)
- Nuclear Factor- (cid:1) B Protects the Adult Cardiac Myocyte Against Ischemia-Induced Apoptosis in a Murine Model of Acute Myocardial Infarction (2003) (8)
- Treatment of Heart Failure Beyond Practice Guidelines (2008) (8)
- Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope Dependence. (2019) (8)
- Correction for Lavine et al., Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart (2016) (7)
- A Textbook of Cardiovascular Medicine NINTH EDITION (2010) (7)
- Treatment of heart failure beyond practice guidelines. Role of cardiac remodeling. (2008) (7)
- Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial (2019) (7)
- Artificial Intelligence Discusses the Role of Artificial Intelligence in Translational Medicine (2023) (7)
- Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. (2015) (7)
- The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Trial (2020) (7)
- Comorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients (2020) (7)
- Stroke in Heart Failure in Sinus Rhythm: The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial (2013) (7)
- Use of targeted anticytokine treatments in heart failure. (2000) (6)
- Vagal nerve stimulation for heart failure: new pieces to the puzzle? (2015) (6)
- Inflammation — A new frontier in cardiac disease and therapeutics (2003) (6)
- Translational medicine: mitigating risks for investigators (2013) (6)
- COVID-19 Clinical Trials (2020) (6)
- Tumor necrosis factor-α and tumor necrosis factor receptors in human heart failure (1996) (6)
- The evolution of modern theory and therapy for heart failure (2014) (6)
- Is It Time for a New Taxonomy for Heart Failure? (2016) (6)
- Heart failure: beyond practice guidelines. (2006) (6)
- TNFalpha decreases alphaMHC expression by a NO mediated pathway: role of E-box transcription factors for cardiomyocyte specific gene regulation. (2002) (6)
- raf protooncogene expression in neural and immune tissues. (1988) (6)
- Braunwald's Heart Disease: a textbook of cardiovascular medicine volume 1 (2015) (6)
- Doppler and two-dimensional echocardiographic diagnosis of Björk-Shiley prosthetic valve malfunction: importance of interventricular septal motion and the timing of onset of valve flow. (1986) (6)
- Beta-blockers for the treatment of heart failure with a mid-range ejection fraction: deja-vu all over again? (2018) (6)
- The Art and Challenge of Crafting a Central Illustration or Visual Abstract. (2019) (6)
- JACC: Basic to Translational Science (2018) (6)
- Getting pumped about heart failure. (2014) (6)
- Incident Heart Failure in Chronic Inflammatory Diseases: Is it Time to Rethink Stage A Heart Failure? (2020) (6)
- Signaling pathways involved in left ventricular remodeling: summation. (2002) (6)
- Role of Innate and Adaptive Immunity in Cardiac Injury and Repair (2015) (5)
- Chinese Health Care Workers and COVID-19 (2020) (5)
- Cardiac Sympathetic-Parasympathetic Interaction (2020) (5)
- Early natural history of regional left ventricular dysfunction after experimental myocardial infarction. (1988) (5)
- Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure: Analysis of the LIFE Trial Run-In. (2022) (5)
- The treatment of heart failure in the 21st century: is the glass half empty or half full? (2013) (5)
- (541) – The REVIVAL Registry of Ambulatory Advanced Heart Failure: Baseline Characteristics (2017) (5)
- Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. (2014) (5)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. (2012) (5)
- Colchicine and the failing heart: a "FINER" anti-inflammatory agent? (2014) (5)
- TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte Homeostasis (2021) (5)
- Chapter 11 – Activation of Inflammatory Mediators in Heart Failure (2011) (5)
- COVID-19 Clinical Trials (2020) (5)
- Modulation of left ventricular dilation remodeling with epicardial restraint devices in postmyocardial infarction heart failure (2009) (5)
- Results of a multicenter randomized clinical trial for the assessment of a cardiac support device in patients with heart failure (2005) (5)
- Determinants of myocardial recovery in myocarditis has the time come for molecular fingerprinting? (2005) (4)
- The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Ground (2020) (4)
- The Rising Cost of Developing Cardiovascular Therapies and Reproducibility in Translational Research (2017) (4)
- Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure (2022) (4)
- Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases (2003) (4)
- Publisher Correction: Reappraising the role of inflammation in heart failure (2021) (4)
- RNA Vaccines for COVID-19 (2020) (4)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. (2013) (4)
- Can Mr. Trump Make Translational Research Great Again? (2017) (4)
- Randomized Trial of Aldosterone AntagonisM in Diastolic Heart Failure (RAAM-DHF) (2010) (4)
- Awards and named lecturers at the American Heart Association 71st scientific sessions. (1999) (4)
- Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials (2015) (4)
- Pharmacogenomics and the failing heart are we waiting for godot? (2008) (4)
- Comprar Braunwald's Heart Disease Online | Peter Libby | 9781416041030 | Saunders (2007) (4)
- The Tafamidis Drug Development Program (2018) (4)
- Caregiver Health‐Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVAL (2021) (4)
- Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial. (2017) (3)
- Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes. (2008) (3)
- Heart failure as a consequence of atherosclerotic coronary artery disease (2003) (3)
- Emerging Therapies and Strategies in the Treatment of Heart Failure (2012) (3)
- Unsupervised cluster analysis of patients with recovered left ventricular ejection fraction identifies unique clinical phenotypes (2021) (3)
- Fake News, Alternative Facts, and Things That Just Are Not True (2018) (3)
- Experimental options in the treatment of heart failure: the role of cytokine antagonism. (2001) (3)
- Recognition of self-DNA drives cardiac inflammation: why broken hearts fail (2017) (3)
- The Enemy Within: Immunologic Responses to Cardiac Tissue (1996) (3)
- Cardiac Remodeling as Therapeutic Target: Treating Heart Failure with Cardiac Support Devices (2005) (3)
- The Heart Failure Society of America in 2020: a vision for the future. (2012) (3)
- Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure (2017) (3)
- Potential Effect of Brexit on Cardiovascular Translational Science (2016) (3)
- The Programmed Death-1 Signaling Axis Modulates Inflammation and LV Structure/Function in a Stress-Induced Cardiomyopathy Model (2022) (3)
- The 2017 March for Science (2017) (3)
- (434) - Painting Profiles of Ambulatory Advanced Heart Failure: A Report from the REVIVAL Registry (2017) (3)
- Guidelines, performance measures, and the practice of medicine: mind the gap. (2010) (3)
- Will the Precision Medicine Initiative Transform Cardiovascular Translational Research? (2016) (3)
- The genomics of heart failure: design and rationale of the HERMES consortium (2021) (3)
- Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure (2015) (3)
- Benefit of Warfarin Compared with Aspirin in Heart Failure Patients in Sinus Rhythm: A Subgroup Analysis of WARCEF, a Randomized Controlled Trial Homma et al: WARCEF Subgroup Analysis (2017) (3)
- Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). (2018) (3)
- Molecular imaging and the failing heart: through the looking glass. (2009) (3)
- 711: Mitral Valve Repair (MVR) in Heart Failure: 5 Year Follow-Up from the MVR Stratum of the Acorn Trial (2009) (3)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. (2013) (3)
- Group B StreptococcusInduces TNF-a Gene Expression and Activation of the Transcription Factors NF-kB and Activator Protein-1 in Human Cord Blood Monocytes (2000) (3)
- Light Chains and the Failing Heart: Important Mechanistic Link or Fifty Shades of Gray? (2015) (3)
- Searching for the perfect agent to improve cardiac contractility (2016) (2)
- Ischemia reperfusion injury provokes adverse left ventricular remodeling in dysferlin-deficient hearts through a pathway that involves TIRAP dependent signaling (2020) (2)
- Efficacy and Safety Study of Oxypurinol Added to Standard Therapy in Patients with New York Heart Association Class III-IV Congestive Heart Failure (The OPT-CHF Trial) (2006) (2)
- Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction (2022) (2)
- Cardiology patient page. Shortness of breath. (2003) (2)
- Heart Failure 2021: A Compendium of Translational Success. (2021) (2)
- Abstract 1949: The Protein Kinase MAP4K4 Is Activated in Failing Human Hearts and Mediates Cardiomyocyte Apoptosis in Experimental Models, in vitro and in vivo (2007) (2)
- Diagnostic accuracy of damage-associated molecular patterns (DAMPs) in patients with heart failure with a reduced ejection fraction (2017) (2)
- Abstract 5357: MicroRNA 25 and 29a are Differentially Regulated in SMAD-3 Deficient Mice in Pressure Overload Cardiac Hypertrophy and Decrease Collagen Synthesis in Isolated Cardiac Fibroblasts (2008) (2)
- Quality of Anticoagulation Control in Preventing Adverse Events in Heart Failure Patients in Sinus Rhythm: A Warfarin Aspirin Reduced Cardiac Ejection Fraction Trial (WARCEF) Substudy Homma et al: TTR and Outcomes in WARCEF Trial (2016) (2)
- Highlights of the 2006 scientific sessions of the Heart Failure Society of America: Seattle, Washington, September 10-13, 2006. (2007) (2)
- Current Education of Physicians: Lost in Translation? (2019) (2)
- Abstract 11268: Damage Associated Molecular Patterns (DAMPs) Activate Cardiac Fibroblasts Through Toll-Like Receptor 4: Implications for Myocardial Fibrosis (2012) (2)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. (2012) (2)
- Neurohormonal therapy for congestive heart failure (2004) (2)
- Defining Cardiac Recovery at Single Cell Resolution (2022) (2)
- Abstract 12198: TRAF2 Coordinates With PARKIN to Mediate Mitochondrial Autophagy in Cardiomyocytes (2013) (2)
- Interaction between neurohormones and cytokines in heart failure (1999) (2)
- Heart failure 2008: an update for clinicians. (2008) (2)
- Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention—A Report from the 2021 National Heart, Lung, and Blood Institute Workshop (2022) (2)
- An early relook identifies high-risk trajectories in ambulatory advanced heart failure. (2021) (2)
- Myocardial dysfunction in septic shock: basic mechanisms and emerging concepts (1994) (2)
- Guidelines are merely guidelines. (2011) (2)
- Refining the Reproducibility of a Murine Model of Stress-Induced Reversible Cardiomyopathy. (2022) (2)
- A Report from the Late Breaking Clinical Trials Session of the Annual Scientific Meeting of the Heart Failure Society of America (2002) (2)
- Mechanisms of idiopathic dilated cardiomyopathies (2006) (2)
- The yin/yang of innate stress responses in the heart. (2002) (2)
- Identifying Ambulatory Advanced Heart Failure Patients at High Risk for Death, LVAD or Transplant at 1-year: How Did the REVIVAL Eligibility Criteria Perform? (2018) (2)
- Highlights of the 2009 Scientific Sessions of the Heart Failure Society of America, Boston, MA, September 13-16, 2009 (2010) (2)
- Improved propensity matching for heart failure using neural gas and self-organizing maps (2009) (2)
- Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure (2022) (2)
- The Role of Inflammatory Mediators in the Failing Heart (2001) (2)
- SARS-CoV-2 and Bats (2020) (2)
- Abstract 1613: Toll-like Receptors Modulate Ischemic Preconditioning through a Toll-IL-1 Receptor Domain-Containing Adaptor Protein Dependent Pathway (2006) (1)
- Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction (2019) (1)
- What Are the Off-Target Effects of Plan “S” For Translational Investigators? (2019) (1)
- Will Artificial Intelligence Transform Translational Medicine (2021) (1)
- Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure. (2002) (1)
- Diabetic Cardiomyopathy: Distinct and Preventable Entity or Inevitable Consequence? (2014) (1)
- Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL Registry (2021) (1)
- Unsupervised cluster analysis and mortality risk in the Digitalis Investigation Group (DIG) trial of heart failure (2009) (1)
- GLOBAL LONGITUDINAL STRAIN PREDICTS SUSTAINED RECOVERY OF LV EJECTION FRACTION IN HEART FAILURE PATIENTS ON EVIDENCE BASED MEDICAL THERAPIES (2017) (1)
- Tumor Necrosis Factor Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of (2001) (1)
- 743 Randomised clinical assessment of a cardiac support device (CSD) in advanced heart failure patients not requiring concomitant valve surgery (2005) (1)
- Attenuation of myocardial inflammation by celacade™ (Immune modulation therapy) in a murine model of myosin-induced myocarditis (2004) (1)
- Restoring public trust in scientific research by reducing conflicts of interest. (2019) (1)
- Primary Care Provider's Guide to Cardiology (2000) (1)
- Cytokines in ischemic heart disease and heart failure (2000) (1)
- Warped Speed (2020) (1)
- Cardiac Adrenergic Activation in Heart Failure With Preserved Ejection Fraction (2022) (1)
- A biomarker of inflammation in cardiovascular disease (2003) (1)
- Indications for Hospital Readmission in Patients With Left-Ventricular Assist Devices (LVADs): Outcomes in the Continuous-Flow Era (2010) (1)
- The clinical experience with anti-cytokine therapy in heart failure (2003) (1)
- Profiles of Ambulatory Advanced Heart Failure: A Report from the REVIVAL Registry (2018) (1)
- Now That We Have an Effective Vaccine for COVID-19, Will It Also Inoculate Us Against the Virus of Indifference? (2021) (1)
- JACC: Basic to Translational Science: Adding the Arc of Discovery to the JACC Family. (2017) (1)
- Can One Person Make a Difference? (2019) (1)
- The Role of Inflammatory Mediators in Cardiac Remodeling (2005) (1)
- High-Resolution Chromatin Mapping in Heart Failure: Some Answers, but More Questions (2017) (1)
- What I Learned From the Impeachment Process (2020) (1)
- Empagliflozin and the Prevention of Heart Failure (2017) (1)
- CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM (2016) (1)
- Role of Innate Immunity in Heart Failure (2020) (1)
- Predictors of Outcome in Acute Stroke Patients: Are They Reliable and Potentially Useful? (2017) (1)
- Angiotensin Receptor Blockers in the Treatment of Heart Failure (2007) (1)
- How should we measure cytokines in heart failure? [8] (1996) (1)
- HFSA Working Group Designs for Mechanical Circulatory Support Device Studies (2007) (1)
- JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (1)
- Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial (2022) (0)
- JACC: Basic to Translational Science 2021 Young Author Award Winner (2021) (0)
- EFFECT OF SPIRONOLACTONE ON THE PLASMA PROTEOME IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): IMPACT OF BASELINE N-TERMINAL (NT)-PRO B-TYPE NATRIURETIC PEPTIDE (BNP) LEVELS (2023) (0)
- Rebuttal from Daniel Beard and (2013) (0)
- Update: shortness of breath. (2014) (0)
- Rationale of the EXACT-HF Study Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients : Design and (2013) (0)
- When Pigs Fly What Will the Future of Heart Failure Therapeutics Look Like? (2022) (0)
- JACC: Basic to Translational Science and Preprint Servers (2020) (0)
- VALIDITY AND RELIABILITY OF THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (2013) (0)
- Abstract 2915: Circulating Fas in Subjects with Acute Cardiomyopathy and Myocarditis: Results from IMAC 1 (2007) (0)
- Four-Drug Therapy For Heart Failure with Reduced LV Ejection Fraction - Here and Now. (2022) (0)
- Geographic Differences in Patients With Acute Myocardial Infarction in The PARADISE-MI Trial. (2023) (0)
- Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply. (2022) (0)
- The Thomas Force Young Investigator Award (2021) (0)
- Endothelin antagonism and the failing heart: an unfilled promise, an unmet need, or an unanswered question? (2002) (0)
- Q4 Vital Signs (2019) (0)
- Is there room for the heart in CHEST? (1995) (0)
- The Sad Bells of Ukraine (2022) (0)
- JACC: Basic to Translational Science (2019) (0)
- Quantification of Cytokine mRNAs in Human Myocardial Biopsy Samples by Real-Time Quantitative PCR Technology Using the LightCycler Instrument (2002) (0)
- Targeting Inflammation in Pulmonary Artery Hypertension: Is It Time to Forget About the Lungs? (2021) (0)
- JACC: Basic to Translational Science 2017 Young Author Award Winners (2018) (0)
- Myocardium in Humans Synthase-2 : A Potential Mechanism for Depressed Myocardial Function in Hibernating and Nitric Oxide α Increased Myocardial Gene Expression of Tumor Necrosis Factor (2002) (0)
- Not By Choice: Black Patients With Advanced Heart Failure Are Less Likely To Receive A Vad Or Transplant Despite Their Preferences For Care (2022) (0)
- Can valsartan reduce the occurrence of atrial fibrillation in heart failure patients? (2005) (0)
- Abstract 13207: The First Prognostic Model for Stroke and Death in Patients With Systolic Heart Failure (2013) (0)
- Letter by Taylor et al regarding article, "Hydralazine and isosorbide dinitrate in heart failure: historical perspectives, mechanisms, and future directions". (2011) (0)
- ICU Scoring and Clinical Decision Making (0)
- The role of inflammatory mediators in cardiac hypertrophy, cardiac remodeling and myocardial dysfunction (2005) (0)
- Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial (2018) (0)
- Phi Alpha Theta Initiates (2009) (0)
- 775 Higher myocardial cytokine gene expression in aortic stenosis than in idiopahic dilated cardiomyopathy (2003) (0)
- The Role Of Cardiac Support Devices In The Treatment Of Patients With Heart Failure (2005) (0)
- Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study (2022) (0)
- Highlights of the 2010 scientific sessions of the Heart Failure Society of America, San Diego, California, September 12-15, 2010. (2011) (0)
- Associations of methyl donor and methylation inhibitor levels during anti-oxidant therapy in heart failure (2021) (0)
- Matrix metalloproteinase inhibition in transgenic mice with modified cardiac restricted tumor necrosis factor expression: Effects on left ventricular geometry and function (2003) (0)
- Support Device Restored Left Ventricular Shape (2004) (0)
- PREDICTORS OF DISCORDANCE BETWEEN PATIENT-PREDICTED AND MODEL-PREDICTED PATIENT SURVIVAL IN HEART FAILURE AND ASSOCIATION WITH DEATH IN REVIVAL (2023) (0)
- JACC: Basic to Translational Science 2019 Young Author Award Winner (2020) (0)
- Abstract 3788: The Deleterious Effects of Tumor Necrosis Factor on Cardiac Remodeling Are Mediated by TNF Receptor Associated Factor 2 (2008) (0)
- Abstract 785: Pressure-Overload Induced Cardiac Hypertrophy is Associated with Increased Mortality in SMAD3 Deficient Mice (2006) (0)
- Abstract 1009: TRAF2 Mediates Cytoprotective Signaling in Myocardial Ischemia Reperfusion Injury. (2007) (0)
- Conflict of Laws: Wrongful Death: Suit by Foreign Administrator (1951) (0)
- TNF-a induces desmin modification, aggregation and loss of intercalated disc localization (2007) (0)
- Are Academic Medical Centers Placing Translational Scientists on the Endangered Species List? (2017) (0)
- CHANGING TRENDS IN MECHANICAL CIRCULATORY ASSISTANCE: A SINGLE CENTER EXPERIENCE (2010) (0)
- Future Interests: Contingent Remainders: Destructibility by Merger (1951) (0)
- Association of Comorbid Conditions and Quality of Life in Ambulatory Heart Failure Patients: A Report From REVIVAL (2018) (0)
- Chapter 8 – Molecular and Cellular Mechanisms for Myocardial Recovery (2011) (0)
- Race and Baseline Severity of Heart Failure in the Registry Evaluation for Vital Information on VADs in Ambulatory Life (REVIVAL) (2018) (0)
- Role of CD 14 in the Induction of Myocardial TNF and IL-1 After LPS Challenge (2002) (0)
- JACC: Basic to Translational Science Top Reviewers 2021: With Appreciation (2022) (0)
- The Role of Cardiac Restraint Devices in the Treatment of Patients with Dilated Cardiomyopathy (2009) (0)
- URINARY PROTEINS LEVELS ASSOCIATED WITH OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (2023) (0)
- Do We Currently Have an Ideal Biomarker for Guiding the Management of Heart Failure Patients ? (2003) (0)
- Truth and Truthiness in Translational Research (2017) (0)
- Abstract 3332: Homing of Cardiac Mast Cells Contributes to Myocardial Fibrosis and Diastolic Heart Failure in Mice With Sustained Inflammatory Signaling (2009) (0)
- Pathophysiology of valvular heart disease: basic mechanisms (1991) (0)
- Preface to the Ninth Edition (2012) (0)
- JACC: Basic to Translational Science 2022 Thomas Force Young Investigator Award Winner. (2023) (0)
- Desmin is a target and mediator of caspase dependent TNF-α induced aggregate formation and intercalated disc reorganization (2008) (0)
- Can President Trump’s (Second) Choice for the Secretary of the Department of Human Health and Services Make Translational Research Great Again? (2018) (0)
- Why Do Medical Journals Exist in the 21st Century? (2020) (0)
- Hepcidin Does Not Mediate Anemia in Chronic Heart Failure Patients and Is Suppressed in Chronic Heart Failure (2010) (0)
- Remembering Dr. James T. Willerson (2020) (0)
- JACC: Basic to Translational Science 2021 Thomas Force Young Investigator Award Winner (2022) (0)
- Taxation: Federal Gift Tax: Transfers Made Pursuant to Postnuptial Separation Agreements (1951) (0)
- Statin Use and Survival in Patients with Ischemic and Non-Ischemic Heart Failure: Results of a Meta-Analysis (2007) (0)
- 551: Percutaneous LVAD Support in Refractory Cardiogenic Shock Rapidly and Disparately Modulates Serum Biomarkers of Apoptosis, Neurohormonal Activation, Inflammation, and Extracellular Matrix Remodeling (2010) (0)
- Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. (2023) (0)
- In the Ongoing Conflict Between Ideology and Immunity, Which Side Will Protect the Children From Post-Acute Sequelae of COVID-19? (2021) (0)
- Toll-like Receptor 2 Modulates Left Ventricular Function Following Ischemia-Reperfusion Injury Running Head : TLR 2 and ischemia-reperfusion injury (2006) (0)
- Alterations in Ventricular Structure (2020) (0)
- The Law of Holes (2022) (0)
- JACC: Basic to Translational Science 2021 Young Author Award Winner (2021) (0)
- JACC Journals’ Pathway Forward With AI Tools (2023) (0)
- Scott Gottlieb’s Resignation as FDA Commissioner Is a Loss for Translational Medicine (2019) (0)
- JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
- Training the Next Generation of Translational Cardiovascular Investigators (2016) (0)
- The Heartmate Risk Score Predicts Morbidity and Mortality in Unselected LVAD Recipients and Risk Stratifies INTERMACS Class 1 Patients (2016) (0)
- The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial (2022) (0)
- The Role of Cytokines in Clinical Heart Failure (2015) (0)
- JACC: Basic to Translational Science (2016) (0)
- Will Gene Editing Orphanize Rare Diseases? (2023) (0)
- JACC: Basic to Translational Science 2020 Top Reviewers: (2021) (0)
- Abstract 15769: Does HRQOL Decline in Ambulatory Advanced Heart Failure Patients and Their Caregivers Over Time? (2018) (0)
- In Memoriam – Helmut Drexler (2011) (0)
- The Editors welcome submissions for possible publication in the Letters section. Authors of letters should: • Include no more than 300 words of text, three authors, and five (1994) (0)
- Inflammatory Mediators in Heart Failure (2018) (0)
- Taxation: Income Tax: Taxability of Payments Made to Widows of Deceased Employees (1951) (0)
- Abstract 17088: Role of Caregiver Participation in Outcomes for Patients With Advanced Ambulatory Heart Failure: An Analysis of the Revival Registry (2018) (0)
- JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
- Abstract 13892: The Cytoprotective Effects of Tumor Necrosis Factor Are Mediated by Dysferlin: An Emergency Response Gene that Mediates Membrane Repair (2010) (0)
- Myocardial Recovery Is Associated with Molecular Hysteresis in a Model of Conditional Transgenesis (2010) (0)
- 228SAFETY OF A NOVEL SURGICAL THERAPY FOR THE TREATMENT OF ADVANCED HEART FAILURE: REVIEW OF SURGICAL MORBIDITY AND MORTALITY OF ALGISYL-LVR FROM THE AUGMENT-HF TRIAL (2014) (0)
- Full Issue PDF (2020) (0)
- JACC: Basic to Translational Science 2018 Young Author Award Winner (2019) (0)
- Necrotic cardiac myocytes skew macrophage polarization towards a classically activated phenotype (2023) (0)
- Will COVID-19 Transform Translational Medicine? (2020) (0)
- (457) – Slower Gait Speed as a Measure of Frailty Tracks with INTERMACS Profiles, Quality of Life and Predicted Mortality in Ambulatory Patients with Advanced Heart Failure: A Report from the REVIVAL Registry (2017) (0)
- The role of cytokines in inflammation-induced cardiomyopathy: Pathogenesis and therapeutic implications (2010) (0)
- Empagli fl ozin and the Prevention of Heart Failure Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure ? * (2017) (0)
- The Affordable Care Act’s Hospital Readmissions Reduction Program (2016) (0)
- PROTEOMIC ASSOCIATIONS OF N-TERMINAL (NT)-PRO HORMONE BNP (NT-PROBNP) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) (2023) (0)
- IMPAIRED AUTOPHAGIC FLUX CONTRIBUTES TO THE ACCUMULATION OF UBIQUITINATED PROTEINS IN A MOUSE MODEL OF HEART FAILURE (2017) (0)
- Future Interests: Suspension of Power of Alienation: Effect of Trustee's Power to Sell and Reinvest (1951) (0)
- Improved Predictive Models of Mortality in Chronic Heart Failure Using Time-Series Measurements of Inflammatory Biomarkers (2010) (0)
- (503) - Health-Related Quality of Life and Treatment Preferences in Ambulatory Heart Failure - Results from the REVIVAL Study (2017) (0)
- 6: Percutaneous LVAD Support Reverses Neurohormonal Dysregulation and Apoptosis but Increases Inflammation in Profound Refractory Cardiogenic Shock (2009) (0)
- Impact of socioeconomic factors on patient desire for LVAD therapy (2018) (0)
- Defining cardiac functional recovery in end-stage heart failure at single-cell resolution (2023) (0)
- Highlighting the Unique Challenges Presented by Device Trials in Heart Failure (2022) (0)
- Negative Inotropic Effects of High Mobility Box Group 1 Protein in Isolated Contracting Cardiac Myocytes (2013) (0)
- Associations of methyl donor and methylation inhibitor levels during anti-oxidant therapy in heart failure (2021) (0)
- Quality of Life and Treatment Preference for VAD therapy in Ambulatory Advanced Heart Failure: A Report from the REVIVAL Study (2020) (0)
- 718-2 Functional Effects of TNFα Gene Expression in the Heart (1995) (0)
- JACC: Basic to Translational Science: The Apple That Falls Closely to the JACC Family Tree. (2018) (0)
- Chapter 4 Mud crab aquaculture (0)
- Abstract 114: Myocardial B Cells Regulate the Composition of Leukocytes in the Heart as Well as Myocardial Growth (2019) (0)
- 1012-122 Chronic treatment with carvedilol improves left ventricular pump performance by increasing intrinsic myocardial contractility in patients with heart failure (2004) (0)
- The Heart Mate Risk Score Correlates with Mortality in an Unselected Mixed Cohort of Heart Mate II and Heart Ware LVAD from a Single Large Volume Center (2014) (0)
- Full Issue PDF (2020) (0)
- PRENATAL ASPIRIN USE IS ASSOCIATED WITH REDUCED INCIDENCE OF POSTPARTUM HYPERTENSION AMONG WOMEN WITH PREECLAMPSIA (2020) (0)
- JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
- EFFECT OF TRANSFORMING GROWTH FACTOR- β RECEPTOR ANTAGONISM IN MICE WITH CARDIAC RESTRICTED OVEREXPRESSION OF TUMOR NECROSIS FACTOR (2013) (0)
- Reperfusion Injury Dysferlin Mediates the Cytoprotective Effects of TRAF 2 Following Myocardial Ischemia Online (2018) (0)
- How should we measure cytokines in heart failure? (1996) (0)
- Abstract 4367: Off-Target Effects of the Anticancer Agent Bortezomib (VelcadeTM) in the Mammalian Heart (2008) (0)
- JACC Journals' Pathway Forward With AI Tools: The Future Is Now. (2023) (0)
- JACC: Basic to Translational Science 2019 Young Author Award Winner (2020) (0)
- Energy bars with improved taste (2003) (0)
- gastrointestinal HMII = Heartmate II HMRS = Heartmate Risk Score INTERMACS = Interagency Registry for Mechanically Assisted Circulatory Support LVAD = left ventricular assist device ROC = receiver operating curve Adamo (0)
- Full Issue PDF (2018) (0)
- Abstract 53: Recurrent Stroke in the Warfarin versus Aspirin in Reduced Ejection Fraction (WARCEF) Trial (2014) (0)
- Proteomic Signatures of HeartFailureinRelation to LeftVentricular Ejection Fraction (0)
- A Distinct Inflammatory Milieu in Patients with Right Heart Failure (2023) (0)
- Abstract 1770: Proteasome Switching is Associated with Adverse Cardiac Remodeling in a Transgenic Mouse Model of Sustained Inflammatory Signaling (2008) (0)
- Reply to the Preceding Letter (1988) (0)
- Perspective Guidelines are Merely Guidelines (2011) (0)
- Reversion of mitral valve preclosure in acute aortic insufficiency secondary to infective endocarditis. (1989) (0)
- Inflammatory Mediators in Health and Disease : The Yin Yang of Cardiac Innate Immune Responses (2002) (0)
- Shark Attack (2023) (0)
- Recurrent Myocardial Injury Leads to Disease Tolerance in a Murine Model of Stress-Induced Cardiomyopathy (2023) (0)
- Translational Science, Vaccines, and the Milk of Human Kindness (2021) (0)
- Functional significance of toll-like receptor-2 mediated signaling in the heart following acute ischemia/infarction (2003) (0)
- Abstract 11961: Clinical, Physiologic, and Functional Characterization of Patients With Diabetes and Heart Failure With Preserved Ejection Fraction: Data From the Heart Failure Network RELAX Study (2013) (0)
- PROTEOMIC CORRELATES OF PLASMA POTASSIUM (K+) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) (2023) (0)
- Abstract 11673: Soluble Tumor Necrosis Factor Receptors and Heart Failure Risk in Older Adults: The Health, Aging, and Body Composition Study (2012) (0)
- Comprar Heart Failure: A Companion to Braunwalds Heart Disease. 2nd Edition | Douglas L. Mann | 9781416058953 | Saunders (2010) (0)
- JACC Journals’ Pathway Forward With AI Tools (2023) (0)
- Abstract 18753: Mechanisms of Left Ventricular Reverse Remodeling: Insights From a Novel Murine Model of Hypertensive Ischemic Cardiomyopathy (2013) (0)
- Fake It Till You Make It (2022) (0)
- JACC: Basic to Translational Science Top Reviewers 2022: With Appreciation and Gratitude (2023) (0)
- Abstract 1764: Cross-Talk between Cardiac Mast Cells and Fibroblasts Contributes to Myocardial Fibrosis in a Transgenic Model of Inflammatory Cardiomyopathy (2008) (0)
- Abstract 17562: TRAF2 Mediates Tumor Necrosis Factor Induced Mitochondrial Autophagy (2012) (0)
- Braunwald's Heart Disease Online (2007) (0)
- Abstract 14725: Short-Term Changes in Indices of Disease Severity Impact Prognosis in Advanced Ambulatory Heart Failure (2018) (0)
- Abstract 55: Opposing Roles Of Distinct Macrophage Lineages In Heart Failure And Cardiac Recovery (2014) (0)
- Making Science Fun Again (2022) (0)
- Group B Streptococcus Infection Activates Nuclear Factor Kappa B in Human Cord Blood Monocytes † 928 (1998) (0)
- Tumor Necrosis Factor-α and the Myocardial Stress Response (1997) (0)
- Abstract 9248: The Impact of Heart Failure Progression on Post-Left Ventricular Assist Device Survival: An Analysis of the INTERMACS Registry (2012) (0)
- Recent Insights into the Molecular Pathophysiology of Viral Myocarditis (2005) (0)
- Conflict of Laws: Death by Wrongful Act: Recovery under Foreign Statute (1951) (0)
- Comments on Letter to the Editor entitled: "Role of electrophysiological evaluation for the best device choice to prevent sudden cardiac death in patients with Myotonic Dystrophy Type1 and Emery Dreifuss Muscular Dystrophy". (2017) (0)
This paper list is powered by the following services:
Other Resources About Douglas L. Mann
What Schools Are Affiliated With Douglas L. Mann?
Douglas L. Mann is affiliated with the following schools:
